Sanofi-Aventis (France) Names Dr. Elias Zerhouni President, Global R&D

Wall Street Journal -- LONDON—Sanofi-Aventis S.A. named a new head of research and development Tuesday, as the French drugs giant pushes ahead with plans to redesign its product portfolio to offset revenue that will be lost as patents expire. The company, which will see patent issues take out a third of sales between 2008 and 2013, named Elias Zerhouni its new head of global research and development for medicines and vaccines from Jan. 1, replacing Marc Cluzel.

Back to news